BioVie Inc. - Special CallCompany ParticipantsCuong Viet Do - President, CEO & DirectorConference Call ParticipantsCraig ...
Discover BioVie's latest clinical advancements in Parkinson's, long COVID, and ascites. Learn about investment potential and upcoming data readouts.
Final data analysis from the Dimerix collaboration with PARASOL reinforces the company’s proteinuria-based endpoints in its phase III ACTION3 trial of lead drug DMX-200 in rare kidney disease Focal ...
Most proteins in blood are measured outside their functional and cellular context. Machine learning was used to integrate ...
Complement Therapeutics receives US FDA clearance to begin Opti-GAIN phase I/II trial of CTx001 in patients with GA secondary to AMD: Munich, Germany Thursday, October 9, 2025, 11 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback